Login
$NRXS
$4.75 -$0.05 (1.04%) After hours

Company Executives

Officer Age In this role Joined Source
Brian Carrico Also a director
President, Chief Executive Officer, and Director
44 Not stated Not stated
Timothy Henrichs
Chief Financial Officer
53 Since 2024
2 years
Not stated
Adrian Miranda
CMO, SVP Science & Tech
Title from the Form 4 dated Aug 24, 2026
57 Not stated Not stated
Thomas Carrico
CRO, CCO, CPO
Title from the Form 4 dated Oct 8, 2026
69 Not stated 2012
Craig Thomas Blanchard
Chief Commercial Officer
Title from the Form 3 dated Sep 28, 2026
Not stated Not stated Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
5
serving now
Independent
3 of 3
stated in the proxy; 2 not stated
CEO also chairs the board
No
Bradley Mitch Watkins
Director Age Independent Committees 2025 pay Source
Bradley Mitch Watkins
51 Independent
Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Not stated
Brian Carrico
44 Not stated None stated Paid as CEO
Christopher Robin Brown
72 Not stated None stated Not stated
Beth Keyser
57 Independent
Audit Committee Compensation Committee Nominating and Corporate Governance Committee · Chair
Not stated
Gilad Aharon
52 Independent
Compensation Committee · Chair
$110,883

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

5 disclosed in the proxy filed Apr 28, 2026
two founding shareholders of the Company
founding shareholders
Amount not stated
as of December 31, 2025

Two demand notes receivable from the founding shareholders related to the sale of common stock; no payments received and balances fully reserved.

limited liability company in which the President and Chief Executive Officer and Chief Regulatory, Compliance and Privacy Officer hold an ownership interest
LLC in which the Company's President and Chief Executive Officer and Chief Regulatory, Compliance and Privacy Officer maintain an ownership interest
$4,412
year ended December 31, 2025

Exclusive license for the auricular portion of certain patents owned by the LLC; license costs incurred for patent maintenance.

With the Company Open in proxy
a member of the Company's Board of Directors
member of the Company's Board of Directors
$9,380
year ended December 31, 2025

Board member purchases NeuroStim devices at cost for research and development activities.

With the Company Open in proxy
the Company's former Chief Financial Officer
former Chief Financial Officer; managing partner and majority shareholder of the third-party public accounting firm
$44,365
year ended December 31, 2025

Accounting and tax services contracted on a continuous basis through a third-party public accounting firm.

With a third-party public accounting firm Open in proxy
the Company's former Chief Financial Officer
former Chief Financial Officer
$55,600
June 28, 2024

Issuance of 20,000 common shares with a fair value for services rendered during the IPO process.

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support